Under Bernie Sanders's Glare, Pharmaceutical Chiefs Will Testify on Drug Prices
The chief executives of Johnson & Johnson, Merck, and Bristol Myers Squibb are set to testify in front of the Senate health committee regarding drug pricing in the US.
Senator Bernie Sanders plans to focus the hearing on why drug prices are higher in the US compared to other wealthy countries.
The hearing coincides with the launch of a new federal program that authorizes Medicare to negotiate the prices of some costly medications.
Under Bernie Sanders' glare, pharmaceutical chiefs will testify on drug prices
CEOs of three major pharmaceutical companies to testify before Senate health committee on drug pricing in the US.
The executives are expected to clash with committee chair Bernie Sanders over high drug prices in comparison to other countries.
Under Bernie Sanders's Glare, Pharmaceutical Chiefs Will Testify on Drug Prices
The chief executives of Johnson & Johnson, Merck, and Bristol Myers Squibb are set to testify in front of the Senate health committee regarding drug pricing in the US.
Senator Bernie Sanders plans to focus the hearing on why drug prices are higher in the US compared to other wealthy countries.
The hearing coincides with the launch of a new federal program that authorizes Medicare to negotiate the prices of some costly medications.
Under Bernie Sanders' glare, pharmaceutical chiefs will testify on drug prices
CEOs of three major pharmaceutical companies to testify before Senate health committee on drug pricing in the US.
The executives are expected to clash with committee chair Bernie Sanders over high drug prices in comparison to other countries.